Macroview Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-12
Closed -$10.6K 333
2024
Q3
$10.6K Buy
12
+6
+100% +$5.39K 0.01% 227
2024
Q2
$5.43K Buy
6
+2
+50% +$1.6K 0.01% 355
2024
Q1
$3.11K Hold
4
﹤0.01% 472
2023
Q4
$2.33K Sell
4
-31
-89% -$18.1K ﹤0.01% 505
2023
Q3
$18.8K Buy
35
+23
+192% +$11.9K 0.03% 173
2023
Q2
$5.63K Buy
+12
New +$5.03K 0.01% 331
2020
Q2
Sell
-41
Closed -$6K 354
2020
Q1
$6K Hold
41
0.01% 137
2019
Q4
$5K Hold
41
0.01% 167
2019
Q3
$5K Hold
41
0.01% 167
2019
Q2
$5K Hold
41
0.01% 168
2019
Q1
$5K Hold
41
0.01% 176
2018
Q4
$5K Hold
41
0.02% 157
2018
Q3
$4K Buy
+41
New +$4.1K 0.01% 185
2015
Q1
Sell
-4
Closed 189
2014
Q4
$0 Hold
4
﹤0.01% 244
2014
Q3
$0 Buy
+4
New +$253 ﹤0.01% 260
2014
Q2
Sell
-12
Closed -$1K 222
2014
Q1
$1K Sell
12
-300
-96% -$16.7K ﹤0.01% 259
2013
Q4
$16K Hold
312
0.03% 75
2013
Q3
$16K Hold
312
0.03% 73
2013
Q2
$15K Buy
+312
New +$17K 0.02% 65

Other funds holding LLY

Macroview Investment Management's LLY Position: Q4 2024 in Review

Macroview Investment Management sold out of Eli Lilly (LLY) in Q4 2024, closing a stake of 12 shares — an estimated $10.6K sold.

Macroview Investment Management first reported a position in LLY in Q2 2013 and held it in 19 quarters. The position peaked at $18.8K in Q3 2023. 3,906 funds tracked by Wall St. Rank hold LLY as of Q4 2024.

  • Macroview Investment Management reported no remaining Eli Lilly position as of Q4 2024 after selling out during the quarter.
  • Macroview Investment Management sold 12 Eli Lilly shares in Q4 2024, an estimated $10.6K.
  • Macroview Investment Management first reported a position in Eli Lilly in Q2 2013 and held it in 19 quarters.
  • Macroview Investment Management's Eli Lilly position peaked at $18.8K in Q3 2023.
  • 3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2024.

Based on Macroview Investment Management's 13F filing for Q4 2024, filed 31 Jan 2025.